Jun. 6—June is post-traumatic stress disorder awareness month. The Brain and Behavior Research Foundation answers five frequently asked questions. 1 What is Post-Traumatic Stress Disorder? "Post ...

Psychiatric nurse practitioner Zach Backlin answers all your PTSD questions. 70 percent of adults experience at least one traumatic event in their lifetime; one-fifth of those people will develop ...

As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence By Will Stone (NPR) May 13, 2024 10:33 a.m.

Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates ...

Psychiatry > Anxiety & Stress FDA Staff Questions Safety of MDMA Treatment for PTSD — Advisory committee will weigh benefits and risks next week by Michael DePeau-Wilson, Enterprise ...

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD The drug application is part of a decade-long effort by advocates to move psychedelic drugs into the medical mainstream.

In its report, ICER acknowledges that the MDMA data suggest it would be an "important addition to treatment options for PTSD," but it questions whether the published findings tell the full story.

Federal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD.

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD The drug application is part of a decade-long effort by advocates to move psychedelic drugs into the medical mainstream.